Skip to content
2000
Volume 20, Issue 3
  • ISSN: 2772-4344
  • E-ISSN: 2772-4352

Abstract

Background

Tinea infections are superficial fungal infections caused by three species of fungi ( Epidermophyton, Microsporum, and Trichophyton) collectively termed dermatophytes. Dermatophytes are fungi that cause skin, nail bed, and hair infections. These infections are classified based on infection site, including tinea pedis (foot), tinea corporis (body), tinea capitis (head), and tinea cruris (groin). Dermatophytes can spread by direct contact with other people (anthropophilic organisms), animals (zoophilic organisms), and soil (geophilic organisms), as well as indirectly from fomities.

Objective

This review aims to summarize the allopathic drugs along with their mechanism of action and herbal drugs including their parts of the plant used for the treatment of tinea infections.

Methods

The literature review was performed using the following databases: PubMed (https://pubmed.ncbi.nlm.nih.gov/), and Google Scholar (https://scholar.google.com/), to identify the various drugs involved in the treatment of dermatophytosis along with their mechanisms.

Results

The following keywords were applied in the search strategy: “Tinea”, “Dermatophytosis”, “Ringworm infection”, “Pathogenesis of tinea”, “Tinea pedis”, and “Tinea capitis”. This article also reviews several formulations that are available in the market for treating ringworm infection.

Conclusion

The current review provides information about the classification of dermatophytosis based on infection site and environmental habitat, pathogenesis, immunopathogenesis of dermatophytes, and herbals and allopathic drugs used for their treatment.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/raaidd/10.2174/0127724344305611241113174748
2025-01-03
2025-12-27

  • From This Site

    /content/journals/raaidd/10.2174/0127724344305611241113174748
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. The World health report: 2004: Changing history.2004Available from: https://iris.who.int/bitstream/handle/10665/42891/924156265X.pdf
    [Google Scholar]
  2. MartinA.G. KobayashiG.S. Superficial fungal infection.In: Fitzpatrick’s Dermatology in General Medicine.McGraw Hill199923372357
     [Google Scholar]
  3. WatkinsJ. Symptoms and treatment of ringworm infections.Br J School Nurs201493
     [Google Scholar]
  4. GuptaB.K. KumarS. KumarR.A. KhuranaS. Mycological aspects of dermatomycosis in Ludhiana.Indian J. Pathol. Microbiol.1993363233237 8300168
     [Google Scholar]
  5. PatwardhanN. DaveR. Dermatomycosis in and around Aurangabad.Indian J. Pathol. Microbiol.1999424455462 11127378
     [Google Scholar]
  6. JainN. SharmaM. SaxenaV.N. Clinico-mycological profile of dermatophytosis in Jaipur, Rajasthan.Indian J. Dermatol. Venereol. Leprol.200874327427510.4103/0378‑6323.41388 18583809
     [Google Scholar]
  7. SharmaM. SharmaR. Profile of dermatophytic and other fungal infections in jaipur.Indian J. Microbiol.201252227027410.1007/s12088‑011‑0217‑z 23729893
     [Google Scholar]
  8. MeghanaT. SailajaA.K. Herbal antifungal agents used for the treatment of fungal infections.Clin Case Rep Clin Study20215414
     [Google Scholar]
  9. GrubyD. Memory on a vegetation which constitutes the real ringworm.CR Acad Sci1841137275
     [Google Scholar]
  10. GrubyD. On the mycoderms which constitute the ringworm.CR Acad Sci184113309312
     [Google Scholar]
  11. GrubyD. Research on the nature, location and development of Porrigo decalvans or Phytoalopecia.CR Acad Sci184317301302
     [Google Scholar]
  12. GrubyD. Research on cryptogams which constitute the contagious disease of the scalp described under the name Tinea tondante (Mahon), Herpes tonsurans (Cazenave).CR Acad Sci184418583585
     [Google Scholar]
  13. OddsF.C. Sabouraud('s) agar.Med. Mycol.199129635535910.1080/02681219180000581 1815027
     [Google Scholar]
  14. Kwon-ChungK.J. BennettJ.E. Medical mycology.Rev. Inst. Med. Trop. São Paulo199234650410.1590/S0036‑46651992000600018
     [Google Scholar]
  15. EmmonsC.W. Dermatophytes: Natural grouping based on the form of the spores and accessory organs.Arch. Derm. Syphilol.193430333736210.1001/archderm.1934.01460150003001
     [Google Scholar]
  16. BenhamRW Nutritional studies of the dermatophytes; Effect on growth and morphology, with special reference to the production of macroconidia.Trans N Y Acad Sci1953154 Series II102610.1111/j.2164‑0947.1953.tb00327.x 13038984
     [Google Scholar]
  17. SilvaM. BenhamR.W. Nutritional studies of the dermatophytes with special reference to Trichophyton Megnini Blanchard 1896 and Trichophyton gallinae (Megnin 1881) comb.J. Invest. Dermatol.195218645347210.1038/jid.1952.55 14938662
     [Google Scholar]
  18. AjelloL. GeorgL.K. In vitro hair cultures for differentiating between atypical isolates of Trichophyton mentagrophytes and Trichophyton rubrum.Mycopathologia19578131710.1007/BF02053114 13430694
     [Google Scholar]
  19. GeorgL.K. Cultural and nutritional studies of richophyton gallinae and Trichophyton megnini.Mycologia195244447049210.1080/00275514.1952.12024210
     [Google Scholar]
  20. GeorgL.K. CampL.B. Routine nutritional tests for the identification of dermatophytes.J. Bacteriol.195774211312110.1128/jb.74.2.113‑121.1957 13475205
     [Google Scholar]
  21. SwartzH.E. GeorgL.K. The nutrition of Trichophyton tonsurans.Mycologia195547447549310.1080/00275514.1955.12024470
     [Google Scholar]
  22. DawsonC.O. GentlesJ.C. Addendum to: The perfect states of Keratinomyces ajelloi Vanbreuseghem, Trichophyton terrestre Dune & Frey and Microsporum nanum Fuentes’.Sabouraudia196112123
     [Google Scholar]
  23. VanbreuseghemR. Biological technique for isolating dermatophytes from soil.Ann. Soc. Belg. Med. Trop.1952322173178 14953089
     [Google Scholar]
  24. GriffinD.M. The re-discovery of Gymnoascus gypseum, the perfect state of Microsporum gypseum, and a note on Trichophyton terrestre.Trans. Br. Mycol. Soc.1960434637IN610.1016/S0007‑1536(60)80054‑X
     [Google Scholar]
  25. StockdaleP.M. Nannizzia incurvata gen. nov., sp. nov., A perfect state of Microsporum gypseum (Bodin) Guiart et Grigorakis.Med. Mycol.196211414810.1080/00362176285190101
     [Google Scholar]
  26. StockdaleP.M. The Microsporum gypseum complex (Nannizzia incurvata Stockd., N. gypsea (Nann.) comb. nov., N. fulva sp. nov.).Med. Mycol.19643111412610.1080/00362176485190161 5896180
     [Google Scholar]
  27. WeitzmanI. Variation in Microsporum gypseum. I. A genetic study of pleomorphism.Med. Mycol.19643319520410.1080/00362176485190341 5896099
     [Google Scholar]
  28. WeitzmanI. Incompatibility in the Microsporum gypseum complex.Mycologia196456342543510.1080/00275514.1964.12018127
     [Google Scholar]
  29. GentlesJ.C. Experimental ringworm in guinea pigs: Oral treatment with griseofulvin.Nature1958182463347647710.1038/182476a0 13577889
     [Google Scholar]
  30. BressaniV.O. SantiT.N. Domingues-FerreiraM. AlmeidaA. DuarteA.J.S. Moraes-VasconcelosD. Characterization of the cellular immunity in patients presenting extensive dermatophytoses due to Trichophyton rubrum.Mycoses201356328128810.1111/myc.12018 23145831
     [Google Scholar]
  31. BraschJ. Current knowledge of host response in human tinea.Mycoses200952430431210.1111/j.1439‑0507.2008.01667.x 19207841
     [Google Scholar]
  32. SamantaI. Veterinary Mycology.New DelhiSpringer201510.1007/978‑81‑322‑2280‑4
     [Google Scholar]
  33. ZuritaJ. HayR.J. Adherence of dermatophyte microconidia and arthroconidia to human keratinocytes in vitro.J. Invest. Dermatol.198789552953410.1111/1523‑1747.ep12461067 3668298
     [Google Scholar]
  34. VermoutS. TabartJ. BaldoA. MathyA. LossonB. MignonB. Pathogenesis of dermatophytosis.Mycopathologia20081665-626727510.1007/s11046‑008‑9104‑5 18478361
     [Google Scholar]
  35. BaldoA. MonodM. MathyA. Mechanisms of skin adherence and invasion by dermatophytes.Mycoses201255321822310.1111/j.1439‑0507.2011.02081.x 21831104
     [Google Scholar]
  36. KasperovaA. KunertJ. RaskaM. The possible role of dermatophyte cysteine dioxygenase in keratin degradation.Med. Mycol.201351544945410.3109/13693786.2013.794310 23758130
     [Google Scholar]
  37. AljabreS.H.M. RichardsonM.D. ScottE.M. ShanklandG.S. Germination of Trichophyton mentagrophytes on human stratum corneum in vitro.Med. Mycol.199230214515210.1080/02681219280000191 1588464
     [Google Scholar]
  38. HavlickovaB. CzaikaV.A. FriedrichM. Epidemiological trends in skin mycoses worldwide.Mycoses200851Suppl. 421510.1111/j.1439‑0507.2008.01606.x 18783559
     [Google Scholar]
  39. WeitzmanI. SummerbellR.C. The dermatophytes.Clin. Microbiol. Rev.19958224025910.1128/CMR.8.2.240 7621400
     [Google Scholar]
  40. DuekL. KaufmanG. UlmanY. BerdicevskyI. The pathogenesis of dermatophyte infections in human skin sections.J. Infect.200448217518010.1016/j.jinf.2003.09.008 14720494
     [Google Scholar]
  41. ZiółkowskaG. NowakiewiczA. GnatS. TrościańczykA. ZiębaP. MajerD.B. Molecular identification and classification of Trichophyton mentagrophytes complex strains isolated from humans and selected animal species.Mycoses201558311912610.1111/myc.12284 25643744
     [Google Scholar]
  42. GnatS. NowakiewiczA. ŁagowskiD. ZiębaP. Host- and pathogen-dependent susceptibility and predisposition to dermatophytosis.J. Med. Microbiol.201968682383610.1099/jmm.0.000982 31050630
     [Google Scholar]
  43. MorielloK.A. CoynerK. PatersonS. MignonB. Diagnosis and treatment of dermatophytosis in dogs and cats.Vet. Dermatol.2017283266e6810.1111/vde.12440 28516493
     [Google Scholar]
  44. DeBoerD.J. MorielloK.A. Development of an experimental model of Microsporum canis infection in cats.Vet. Microbiol.199442428929510.1016/0378‑1135(94)90060‑4 9133054
     [Google Scholar]
  45. SardanaK. GuptaA. MathachanS.R. Immunopathogenesis of dermatophytoses and factors leading to recalcitrant infections.Indian Dermatol. Online J.202112338939910.4103/idoj.IDOJ_503_20 34211904
     [Google Scholar]
  46. CalderonR.A. MackenzieD.W.R. Immunoregulation of dermatophytosis.CRC Crit. Rev. Microbiol.198916533936810.3109/10408418909104472 2651010
     [Google Scholar]
  47. ReisA.P.C. CorreiaF.F. JesusT.M. In situ immune response in human dermatophytosis: Possible role of Langerhans cells (CD1a+) as a risk factor for dermatophyte infection.Rev. Inst. Med. Trop. São Paulo201961e5610.1590/s1678‑9946201961056 31618376
     [Google Scholar]
  48. TainwalaR. SharmaY.K. Pathogenesis of dermatophytoses.Indian J. Dermatol.201156325926110.4103/0019‑5154.82476 21772583
     [Google Scholar]
  49. VermaA.H. GaffenS.L. Dermatophyte immune memory is only skin-deep.J. Invest. Dermatol.2019139351751910.1016/j.jid.2018.10.022 30797318
     [Google Scholar]
  50. SinghA. MasihA. KhuranaA. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene.Mycoses201861747748410.1111/myc.12772 29577447
     [Google Scholar]
  51. CalichV.L. BlottaM.H. Pulmonary paracoccidioidomycosis. In: Fidel PL, Huffnagle GB, EdsFungal Immunology. FidelP.L. HuffnagleG.B. Boston, MASpringer200520122710.1007/0‑387‑25445‑5_10
     [Google Scholar]
  52. WaldmanA. SegalR. BerdicevskyI. GilharA. CD4+ and CD8+ T cells mediated direct cytotoxic effect against Trichophyton rubrum and Trichophyton mentagrophytes.Int. J. Dermatol.201049214915710.1111/j.1365‑4632.2009.04222.x 19968718
     [Google Scholar]
  53. TraynorT.R. HuffnagleG.B. Role of chemokines in fungal infections.Med. Mycol.2001391415010.1080/mmy.39.1.41.50 11270407
     [Google Scholar]
  54. Al HasanM. FitzgeraldS.M. SaoudianM. KrishnaswamyG. Dermatology for the practicing allergist: Tinea pedis and its complications.Clin. Mol. Allergy200421510.1186/1476‑7961‑2‑5 15050029
     [Google Scholar]
  55. SaraivaM. O’GarraA. The regulation of IL-10 production by immune cells.Nat. Rev. Immunol.201010317018110.1038/nri2711 20154735
     [Google Scholar]
  56. GaffenS.L. Hernández-SantosN. PetersonA.C. IL-17 signaling in host defense against Candida albicans.Immunol. Res.2011502-318118710.1007/s12026‑011‑8226‑x 21717069
     [Google Scholar]
  57. HupplerA.R. ContiH.R. Hernández-SantosN. DarvilleT. BiswasP.S. GaffenS.L. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis.J. Immunol.201419241745175210.4049/jimmunol.1302265 24442441
     [Google Scholar]
  58. WoodfolkJ.A. SungS.S.J. BenjaminD.C. LeeJ.K. Platts-MillsT.A.E. Distinct human T cell repertoires mediate immediate and delayed-type hypersensitivity to the Trichophyton antigen, Tri r 2.J. Immunol.200016584379438710.4049/jimmunol.165.8.4379 11035075
     [Google Scholar]
  59. WoodfolkJ.A. WheatleyL.M. PiyasenaR.V. BenjaminD.C. Platts-MillsT.A.E. Trichophyton antigens associated with IgE antibodies and delayed type hypersensitivity. Sequence homology to two families of serine proteinases.J. Biol. Chem.199827345294892949610.1074/jbc.273.45.29489 9792655
     [Google Scholar]
  60. WeinsteinA. BermanB. Topical treatment of common superficial tinea infections.Am. Fam. Physician2002651020952102 12046779
     [Google Scholar]
  61. Van HeesC. NaafsB. Common Skin Diseases in Africa: An Illustrated Guide.Stichting TrodermaVan Hees2011
     [Google Scholar]
  62. ElewskiB.E. Tinea capitis: A current perspective.J. Am. Acad. Dermatol.200042112010.1016/S0190‑9622(00)90001‑X 10607315
     [Google Scholar]
  63. MoriartyB. HayR. Morris-JonesR. The diagnosis and management of tinea.BMJ20123451e438010.1136/bmj.e4380 22782730
     [Google Scholar]
  64. SegalE. EladD. Human and zoonotic dermatophytoses: Epidemiological aspects.Front. Microbiol.20211271353210.3389/fmicb.2021.713532 34421872
     [Google Scholar]
  65. KiddS. HallidayC. EllisD. Descriptions of Medical Fungi.4th edCABI202210.1079/9781800622340.0000
     [Google Scholar]
  66. García-AgudoL. Espinosa-RuizJ.J. Tinea capitis due to Microsporum gypseum, a rare species.Arch. Argent. Pediatr.20181162e296e299 29557619
     [Google Scholar]
  67. SeebacherC. BoucharaJ.P. MignonB. Updates on the epidemiology of dermatophyte infections.Mycopathologia20081665-633535210.1007/s11046‑008‑9100‑9 18478365
     [Google Scholar]
  68. WhiteT.C. FindleyK. DawsonT.L. Fungi on the skin: dermatophytes and Malassezia.Cold Spring Harb. Perspect. Med.201448a01980210.1101/cshperspect.a019802 25085959
     [Google Scholar]
  69. AchtermanR.R. SmithA.R. OliverB.G. WhiteT.C. Sequenced dermatophyte strains: Growth rate, conidiation, drug susceptibilities, and virulence in an invertebrate model.Fungal Genet. Biol.201148333534110.1016/j.fgb.2010.11.010 21145410
     [Google Scholar]
  70. LeungA.K.C. LamJ.M. LeongK.F. HonK.L. Tinea corporis: An updated review.Drugs Context2020911210.7573/dic.2020‑5‑6 32742295
     [Google Scholar]
  71. BelhadjaliH. AounallahA. YoussefM. GorciiM. BabbaH. ZiliJ. Tinea faciei, underrecognized because clinically misleading. 14 cases.Presse Med.20093891230123410.16/j.lpm.2008.10.017 19217248
     [Google Scholar]
  72. AlterasI. SandbankM. DavidM. SegalR. 15-year survey of tinea faciei in the adult.Dermatology19881772656910.1159/000248519 2971583
     [Google Scholar]
  73. GuptaA.K. SummerbellR.C. Tinea capitis.Med. Mycol.200038425528710.1080/mmy.38.4.255.287 10975696
     [Google Scholar]
  74. TaghipourS. PchelinI.M. Zarei MahmoudabadiA. Trichophyton mentagrophytes and T. interdigitale genotypes are associated with particular geographic areas and clinical manifestations.Mycoses201962111084109110.1111/myc.12993 31444823
     [Google Scholar]
  75. LiH. WuS. MaoL. Human pathogenic fungus Trichophyton schoenleinii activates the NLRP3 inflammasome.Protein Cell20134752953810.1007/s13238‑013‑2127‑9 23686720
     [Google Scholar]
  76. VermaS.B. PandaS. NenoffP. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options.Indian J. Dermatol. Venereol. Leprol.202187446848210.25259/IJDVL_303_20 34219433
     [Google Scholar]
  77. UhrlaßS. VermaS.B. GräserY. Trichophyton indotineae - An emerging pathogen causing recalcitrant dermatophytoses in India and worldwide - A multidimensional perspective.J. Fungi (Basel)20228775710.3390/jof8070757 35887512
     [Google Scholar]
  78. BishnoiA. VinayK. DograS. Emergence of recalcitrant dermatophytosis in India.Lancet Infect. Dis.201818325025110.1016/S1473‑3099(18)30079‑3 29485088
     [Google Scholar]
  79. PierA.C. SmithJ.M. AlexiouH. EllisD.H. LundA. PritchardR.C. Animal ringworm - Its aetiology, public health significance and control.J. Med. Vet. Mycol.199432Suppl. 113315010.1080/02681219480000791
     [Google Scholar]
  80. KrzyściakP. Al-HatmiA.M.S. AhmedS.A. MacuraA.B. Rare zoonotic infection with Microsporum persicolor with literature review.Mycoses201558951151510.1111/myc.12341 26103049
     [Google Scholar]
  81. EnglishM.P. Trichophyton persicolor infection in the field vole and pipistrelle bat.Med. Mycol.19664421922210.1080/00362176685190501 6006211
     [Google Scholar]
  82. BegumJ. KumarR. Prevalence of dermatophytosis in animals and antifungal susceptibility testing of isolated Trichophyton and Microsporum species.Trop. Anim. Health Prod.2021531310.1007/s11250‑020‑02476‑3 33196912
     [Google Scholar]
  83. VeraldiS. GenoveseG. PeanoA. Tinea corporis caused by Trichophyton equinum in a rider and review of the literature.Infection201846113513710.1007/s15010‑017‑1067‑3 28879496
     [Google Scholar]
  84. MorettiA. BoncioL. PasqualiP. FiorettiD.P. Epidemiological aspects of dermatophyte infections in horses and cattle.Zentralbl. Veterinarmed. B.199845420520810.1111/j.1439‑0450.1998.tb00784.x
     [Google Scholar]
  85. ChermetteR. FerreiroL. GuillotJ. Dermatophytoses in animals.Mycopathologia20081665-638540510.1007/s11046‑008‑9102‑7 18478363
     [Google Scholar]
  86. DurduM. IlkitM. TamadonY. TolooeA. RafatiH. SeyedmousaviS. Topical and systemic antifungals in dermatology practice.Expert Rev. Clin. Pharmacol.201710222523710.1080/17512433.2017.1263564 27868472
     [Google Scholar]
  87. EdeogaH.O. OkwuD.E. MbaebieB.O. Phytochemical constituents of some Nigerian medicinal plants.Afr. J. Biotechnol.20054768568810.5897/AJB2005.000‑3127
     [Google Scholar]
  88. AkinmoladunA.C. IbukunE.O. AforE. ObuotorE.M. FarombiE.O. Phytochemical constituent and antioxidant activity of extract from the leaves of Ocimum gratissimum.Sci. Res. Essays200725163166
     [Google Scholar]
  89. RoutS.P. ChoudaryK.A. KarD.M. DasL.O. JainA. Plants in traditional medicinal system-future source of new drugs.Int. J. Pharm. Pharm. Sci.200911123
     [Google Scholar]
  90. Di SantoR. Natural products as antifungal agents against clinically relevant pathogens.Nat. Prod. Rep.20102771084109810.1039/b914961a 20485730
     [Google Scholar]
  91. TomishimaM. OhkiH. YamadaA. MakiK. IkedaF. Novel echinocandin antifungals. Part 1: Novel side-chain analogs of the natural product FR901379.Bioorg. Med. Chem. Lett.20081841474147710.1016/j.bmcl.2007.12.062 18207736
     [Google Scholar]
  92. AbadM.J. AnsuateguiM. BermejoP. Active antifungal substances from natural sources.Arkivoc20077116145
     [Google Scholar]
  93. BarrettD. From natural products to clinically useful antifungals.Biochim. Biophys. Acta Mol. Basis Dis.200215872-322423310.1016/S0925‑4439(02)00085‑6
     [Google Scholar]
  94. TahaK.F. El-hawaryS.S. El-hefnawyH.M. MabroukM.I. SanadR.A. El HarriryM.Y. Formulation and assessment of a herbal hair cream against certain dermatophytes.Int. J. Pharm. Pharm. Sci.2016167173
     [Google Scholar]
  95. MastanA. Anti-fungal potency of some Unani drugs in the treatment of dermatophytoses (Qūba).TMR Integr Med20215e2100410.12032/TMRIM202105004
     [Google Scholar]
  96. MudhaliyarM. Siddha Materia Medica. Part 1, 7th ED. Chennai, India: Indian medicine and Homoeopathy2003
     [Google Scholar]
  97. SamuelJ.K. AndrewsB. JebashreeH.S. In vitro evaluation of the antifungal activity of Allium sativum bulb extract against Trichophyton rubrum, a human skin pathogen.World J. Microbiol. Biotechnol.200016761762010.1023/A:1008972016316
     [Google Scholar]
  98. AdejumoT.O. BamideleB.S. Control of dermatophyte-causing agents (Trichophyton mentagrophytes and Trichophyton rubrum) using six medicinal plants.J. Med. Plants Res.2009311906913
     [Google Scholar]
  99. KisangauD.P. HerrmannT.M. Utilization and conservation of medicinal plants used for primary health care in Makueni district, Kenya.Int J Biodivers Sci Manag20073318419210.1080/17451590709618172
     [Google Scholar]
  100. AfolayanA.J. GriersonD.S. MbengW.O. Ethnobotanical survey of medicinal plants used in the management of skin disorders among the Xhosa communities of the Amathole District, Eastern Cape, South Africa.J. Ethnopharmacol.2014153122023210.1016/j.jep.2014.02.023 24583071
     [Google Scholar]
  101. MaroyiA. Acacia karroo Hayne: Ethnomedicinal uses, phytochemistry and pharmacology of an important medicinal plant in Southern Africa.Asian Pac. J. Trop. Med.201710435136010.1016/j.apjtm.2017.03.021 28552105
     [Google Scholar]
  102. MishraK.K. DhongadeH.J. BanaraseN.B. RajputD.S. Evaluation of antifungal activity of roots of Achyranthes aspera for ring worm infection.Eur. J. Pharm. Med. Res.201232318320
     [Google Scholar]
  103. Baterun KunsahS.T. ArimurtiA.R. Effect of peel extract and crown of pineapple (Ananas comosus L.Merr) on the growth of Trichophyton rubrum Fungus.2nd International Conference on Health Polytechnic Ministry of Surabaya2022224-29
     [Google Scholar]
  104. MotseiM.L. LindseyK.L. van StadenJ. JägerA.K. Screening of traditionally used South African plants for antifungal activity against Candida albicans.J. Ethnopharmacol.2003862-323524110.1016/S0378‑8741(03)00082‑5 12738093
     [Google Scholar]
  105. GhumanS. NcubeB. FinnieJ.F. McGawL.J. CoopoosamyR.M. Van StadenJ. Antimicrobial activity, phenolic content, and cytotoxicity of medicinal plant extracts used for treating dermatological diseases and wound healing in KwaZulu-Natal, South Africa.Front. Pharmacol.2016732010.3389/fphar.2016.00320 27746731
     [Google Scholar]
  106. ShahidiB.G.H. AghighiS. KarimiN.A. Antibacterial and antifungal survey in plants used in indigenous herbal-medicine of south east regions of Iran.J. Biol. Sci.20044340541210.3923/jbs.2004.405.412
     [Google Scholar]
  107. OmranS. AlsamaraiA. RazzzaqF. Therapeutic efficacy of some extracts of hot pepper fruits (Capsicum annuum) and Sumac seeds (Rhus coriaria) on the growth of some isolated dermatophytes species.Int. J. Med. Sci.201813526210.32441/ijms.v1i3.102
     [Google Scholar]
  108. BhatN.A. BhadwajA. TiwariB.K. Anti-dermatophytic activity Of Catharanthus roseus L.(Leaves).Int J Inno Res Adv Stud201744161165
     [Google Scholar]
  109. AdelA. ElnaggarM. Al-SayedE. RabehM. Secondary metabolites from Carica papaya, and its biological activities: A comprehensive review.Arch Pharm Sci Ain Shams Univ20215233135310.21608/aps.2021.106355.1073
     [Google Scholar]
  110. SinghJ.P. Efficacy of lesser known homoeopathic drugs on skin disorders.Indian J. Res. Homoeopathy2003253&4
     [Google Scholar]
  111. BhatP. HegdeG.R. HegdeG. MulgundG.S. Ethnomedicinal plants to cure skin diseases—An account of the traditional knowledge in the coastal parts of Central Western Ghats, Karnataka, India.J. Ethnopharmacol.2014151149350210.1016/j.jep.2013.10.062 24239890
     [Google Scholar]
  112. NjorogeG.N. BussmannR.W. Ethnotherapeautic management of skin diseases among the Kikuyus of Central Kenya.J. Ethnopharmacol.2007111230330710.1016/j.jep.2006.11.025 17207950
     [Google Scholar]
  113. ImanirampaL. AleleP.E. Antifungal activity of Cleome gynandra L. aerial parts for topical treatment of Tinea capitis: An in vitro evaluation.BMC Complement. Altern. Med.201616119410.1186/s12906‑016‑1187‑9 27391957
     [Google Scholar]
  114. MabonaU. ViljoenA. ShikangaE. MarstonA. Van VuurenS. Antimicrobial activity of southern African medicinal plants with dermatological relevance: From an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound.J. Ethnopharmacol.20131481455510.1016/j.jep.2013.03.056 23545456
     [Google Scholar]
  115. LauK.M. FuL.H. ChengL. Two antifungal components isolated from Fructus Psoraleae and Folium Eucalypti Globuli by bioassay-guided purification.Am. J. Chin. Med.20103851005101410.1142/S0192415X10008421 20821830
     [Google Scholar]
  116. ShaiL.J. McGawL.J. MasokoP. EloffJ.N. Antifungal and antibacterial activity of seven traditionally used South African plant species active against Candida albicans.S. Afr. J. Bot.200874467768410.1016/j.sajb.2008.04.003
     [Google Scholar]
  117. ArkhipovA. SirdaartaJ. RayanP. McDonnellP.A. CockI.E. An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts.Pharmacogn. Commun.201443
     [Google Scholar]
  118. NcikiS. VuurenS. van EykA. de WetH. Plants used to treat skin diseases in northern Maputaland, South Africa: Antimicrobial activity and in vitro permeability studies.Pharm. Biol.201654112420243610.3109/13880209.2016.1158287 27137350
     [Google Scholar]
  119. BelloR.Y. Antifungal activity of henna leaves (Lawsonia inermis L.) against Trichophyton rubrum and Trichophyton interdigitale.Int J Res Rev2020711314320
     [Google Scholar]
  120. AsongJ.A. NdhlovuP.T. KhosanaN.S. AremuA.O. Otang-MbengW. Medicinal plants used for skin-related diseases among the Batswanas in Ngaka Modiri Molema District Municipality, South Africa.S. Afr. J. Bot.2019126112010.1016/j.sajb.2019.05.002
     [Google Scholar]
  121. WelderW.M. Melaleuca alternifolia Australian Tea Tree oil as an effective antifungal agent topically for Tinea unguium (onychomycosis).J Phytopharmacol20209641942210.31254/phyto.2020.9606
     [Google Scholar]
  122. NwachukwuI. Antifungal activities and phytochemical constituents of Nicotiana tabacum leaf extracts on selected dermatophytes. nijerial.J. Microbiol.201731238713875
     [Google Scholar]
  123. KoroishiA.M. FossS.R. CortezD.A.G. Ueda-NakamuraT. NakamuraC.V. Dias FilhoB.P. In vitro antifungal activity of extracts and neolignans from Piper regnellii against dermatophytes.J. Ethnopharmacol.2008117227027710.1016/j.jep.2008.01.039 18394835
     [Google Scholar]
  124. SheehanD.J. HitchcockC.A. SibleyC.M. Current and emerging azole antifungal agents.Clin. Microbiol. Rev.1999121407910.1128/CMR.12.1.40 9880474
     [Google Scholar]
  125. CauwenberghG. DegreefH. HeykantsJ. WoestenborghsR. Van RooyP. HaeveransK. Pharmacokinetic profile of orally administered itraconazole in human skin.J. Am. Acad. Dermatol.198818226326810.1016/S0190‑9622(88)70037‑7 2831254
     [Google Scholar]
  126. AroraP. SardanaK. MahajanK. Intracutaneous pharmacokinetics of oral antifungals and their relevance in recalcitrant cutaneous dermatophytosis: Time to revisit basics.Indian J. Dermatol. Venereol. Leprol.201783673073210.4103/ijdvl.IJDVL_1012_16 28936991
     [Google Scholar]
  127. BaoY. WanZ. LiR. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.Mycopathologia20131751-214114510.1007/s11046‑012‑9571‑6 22983900
     [Google Scholar]
  128. SuchilP. Montero GeiF. RoblesM. Perera-RamírezA. WelshO. MaleO. Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea corporis/cruris and cutaneous candidiasis.Clin. Exp. Dermatol.199217639740110.1111/j.1365‑2230.1992.tb00246.x 1486705
     [Google Scholar]
  129. GreerD.L. Successful treatment of tinea capitis with 2% ketoconazole shampoo.Int. J. Dermatol.200039430230410.1046/j.1365‑4362.2000.00885.x 10809984
     [Google Scholar]
  130. JegasothyB.V. PakesG.E. Oxiconazole nitrate: Pharmacology, efficacy, and safety of a new imidazole antifungal agent.Clin. Ther.1991131126141 2029718
     [Google Scholar]
  131. GuptaA.K. FoleyK.A. VersteegS.G. New antifungal agents and new formulations against dermatophytes.Mycopathologia20171821-212714110.1007/s11046‑016‑0045‑0 27502503
     [Google Scholar]
  132. ElewskiB.E. VlahovicT.C. Econazole nitrate foam 1% for the treatment of tinea pedis: Results from two double-blind, vehicle-controlled, phase 3 clinical trials.J. Drugs Dermatol.2014137803808 25007362
     [Google Scholar]
  133. KhannaD. BhartiS. Luliconazole for the treatment of fungal infections: An evidence-based review.Core Evid.2014911312410.2147/CE.S49629 25285056
     [Google Scholar]
  134. GiriV.P. Sertaconazole nitrate 2% cream for the treatment of tinea pedis.Nat J Lab Med2016515
     [Google Scholar]
  135. LiR.Y. WangA.P. XuJ.H. Efficacy and safety of 1% terbinafine film-forming solution in Chinese patients with tinea pedis: A randomized, double-blind, placebo-controlled, multicenter, parallel-group study.Clin. Drug Investig.201434322323010.1007/s40261‑014‑0171‑8 24477462
     [Google Scholar]
  136. GuptaA.K. RyderJ.E. CooperE.A. Naftifine: A review.J. Cutan. Med. Surg.2008122515810.2310/7750.2008.06009 18346400
     [Google Scholar]
  137. Stein GoldL.F. VlahovicT. VermaA. OlayinkaB. FleischerA.B. Naftifine hydrochloride Gel 2%: an effective topical treatment for moccasin-type tinea pedis.J. Drugs Dermatol.2015141011381144 26461826
     [Google Scholar]
  138. ZhangA.Y. CampW.L. ElewskiB.E. Advances in topical and systemic antifungals.Dermatol. Clin.2007252165183, vi.10.1016/j.det.2007.01.002 17430754
     [Google Scholar]
  139. SheikhS. AhmadA. AliS.M. Topical delivery of lipid based amphotericin B gel in the treatment of fungal infection: A clinical efficacy, safety and tolerability study in patients.J. Clin. Exp. Dermatol. Res.201452482
     [Google Scholar]
  140. GuptaA.K. SkinnerA.R. Ciclopirox for the treatment of superficial fungal infections: A review.Int. J. Dermatol.200342Suppl. 13910.1046/j.1365‑4362.42.s1.2.x 12895181
     [Google Scholar]
  141. BardalS.K. WaechterJ.E. MartinD.S. Chapter 18 Infectious diseases.In: Applied pharmacology.Chapter 18Elsevier201123329110.1016/B978‑1‑4377‑0310‑8.00018‑X
     [Google Scholar]
  142. JordáT. PuigS. Regulation of ergosterol biosynthesis in Saccharomyces cerevisiae.Genes (Basel)202011779510.3390/genes11070795 32679672
     [Google Scholar]
  143. Develoux M.Griseofulvin Ann. Dermatol. Venereol.20011281213171325 11908134
     [Google Scholar]
  144. DwivediM. In vitro inhibition of Tinea corporis from various extracts of Aloe vera and Azadirachta indica.Acta Sci Microbiol2018191523
     [Google Scholar]
  145. PatilP.A. KandleH.S. ShelkeG.S. SatheP.T. RohileV.Y. Formulation and evaluation of nanoemulsion comprising of Berberis aristata and Croton tiglium as effective treatment for tinea capitis fungal infection.World J. Pharm. Res.20211014965974
     [Google Scholar]
  146. NautiyalO.H. Anti-fungal activity of Nardostachys jatamansi essential oil beneficial for treating (dermatophytosis) ringworm.J. Nat. Prod.20139241
     [Google Scholar]
  147. BhadauriaS. KumarP. Broad spectrum antidermatophytic drug for the control of tinea infection in human beings.Mycoses201255433934310.1111/j.1439‑0507.2011.02120.x 21929713
     [Google Scholar]
  148. RajakP. PatraE. KarmakarA. BhuyanB. Xanthium strumarium L. extract loaded phyto-niosome gel: Development and in vitro assessment for the treatment of Tinea corporis.Biores Interface in Appl Chem2023133115
     [Google Scholar]
  149. MoghimipourE. AmeriA. SaudatzadehA. SalimiA. SiahpooshA. Formulation of an anti-dermatophyte cream from hydro-alcoholic extract of Eucalyptus camaldulensis leaves.Jundishapur J. Nat. Pharm. Prod.2009413240
     [Google Scholar]
  150. GenatrikaE. SundhaniE. OktavianaM. Gel potential of red onion (Allium cepa L.) ethanol extract as antifungal cause tinea pedis.J. Pharm. Bioallied Sci.202012Suppl. 2S733S73610.4103/jpbs.JPBS_256_19 33828369
     [Google Scholar]
  151. KaushikK. SharmaR.B. SharmaA. AgarwalS. Formulation and evaluation of antifungal activity of gel of crude methanolic extract of leaves of Ipomoea carnea Jacq.J Res Pharm202024336837910.35333/jrp.2020.159
     [Google Scholar]
  152. FawehinmiA.B. OyedejiF.O. Evaluation of formulated anti-dermatophyte creams from ethanol extract of Mitracarpus villosus leaves.Int. J. Biochem. Res. Rev.202029911210.9734/ijbcrr/2020/v29i930219
     [Google Scholar]
  153. Anti fungal foot cream.Available from: https://azanicare.com/products/anti-fungal-foot-cream (Accessed on: Feb.28,2023)
     [Google Scholar]
  154. Facts about tinea capitis infection. Available from: https://www.dovemed.com/slideshows/facts-about-tinea-capitis-infection (Accessed on: Feb.28,2023)
     [Google Scholar]
  155. Terbinaforce cream.Available from: https://www.pulseplus.in/product/terbinaforce-cream-pc-35581?gclid=EAIaIQobChMIsM-f2vm3_QIVQR0rCh1npg8sEAYYBSABEgLHm_D_BwE (Accessed on: Feb.28,2023)
     [Google Scholar]
  156. GrifulvinV. 2021Available from: https://www.rxlist.com/grifulvin-v-drug.htm (Accessed on: Feb. 28, 2023)
  157. Xolegel.2021Available from: https://www.rxlist.com/xolegel-drug.htm (Accessed on: Feb.28,2023)
     [Google Scholar]
  158. Lamisil athelete's foot antifungal cream, full prescription strength for itching, burning, cracking, and scaling, 1 ounce (pack of 2).Available from: https://www.amazon.com/dp/B01IN5FCZ6/?tag=cb-263156-20 (Accessed on: Feb.28,2023)
     [Google Scholar]
  159. Ring guard antifungal medicated cream, 12 gm.Available from: https://www.apollopharmacy.in/otc/ring-guard-cream-12g(Accessed on: Feb.28,2023)
     [Google Scholar]
  160. Lotrimin® AF athlete's foot powder spray.Available from: https://www.lotrimin.com/our-products/athlete-powder-spray#:~:text=Clinically%20proven%20to%20cure%20most,commonly%20known%20as%20athlete's%20foot (Accessed on: March 3, 2023)
     [Google Scholar]
  161. Ayurvedic anti-fungal cream.Available from: https://www.swastikayurveda.co.in/product/swiss-itch-cream/ (Accessed on: March 3, 2023)
     [Google Scholar]
  162. Canesten® dermatological spray.Available from: https://www.canesten.co.uk/discover-canesten-products/canesten-dermatological-spray#:~:text=%C2%AE%20Dermatological%20Spray-,Canesten%C2%AE%20Dermatological%20Spray,the%20fungi%20and%20soothes%20irritation(Accessed on: March 3, 2023)
     [Google Scholar]
  163. Terbicip 1% spray 30ml.Available from: https://www.netmeds.com/prescriptions/terbicip-1-spray-30ml (Accessed on: March 3, 2023)
     [Google Scholar]
  164. StrobelG.A. Method and composition for treating ringworm on biotic and abiotic surfaces.US Patent 20230173004A12023
  165. ThompsonW. Compositions and methods of treatment for tinea pedisUS. Patent 20220062201A12022
  166. HazotY. FeimanJ.N.B. TamarkinD. SchuzD. CaleyS.M. HardasB. Hydroalcoholic foam formulations of naftifine.US Patent 20190282501A12019
  167. WrightK.W. Method for treating and preventing recurrent interdigital tinea pedis (athlete's foot) disease.US Patent 20160287529A12016
  168. BoegliC.J. Topical antifungal composition. US Patent 8449926B22013
  169. ToshimitsuA. FujitaN. KogureT. Adhesive patch for treatment of tinea unguium.US Patent 8574621B22013
  170. GoldsteinJ.A. RothmanM. LoW.Y. Antifungal formulations.US patent 20120165302A12012
  171. HohensteinK. Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues.US patent 20110160166A12011
  172. ChenJ. Pharmaceutical formulation for treating tinea of feet and hands and preparation thereof.US Patent US20090130231A12009
  173. ChauhanV.S. SatyanK.S. KadamK.P. Herbal composition for Tinea infection.US Patent 7635493B22009
/content/journals/raaidd/10.2174/0127724344305611241113174748
Loading
Comprehensive Review on Tinea Infection Therapies: Allopathic and Herbal Approaches for Dermatophytosis
Recent Adv Antiinfect Drug Discov 20, 183 (2025); https://doi.org/10.2174/0127724344305611241113174748
/content/journals/raaidd/10.2174/0127724344305611241113174748
/content/journals/raaidd/10.2174/0127724344305611241113174748
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Dermatophytosis; ringworm; tinea capitis; tinea infection; tinea pedis; Trichophyton rubrum

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test